close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
United Therapeutics Surges 14% on Groundbreaking Tyvaso Phase 3 Results for IPF
Via MarketMinute
Tickers BMY PLRX RHHBY UTHR
Exposures Product Safety
News headline image
Deep Dive: Boston Scientific (BSX) and the New Era of Medical Device Dominance
Via Finterra
Topics Lawsuit Product Recall
Tickers ABT BSX JNJ MDT
Exposures Financial Legal Product Safety
Soligenix Inc. (NASDAQ: SNGX) Expands Pipeline Momentum as SGX945 Earns Global Recognition
Via Investor Brand Network
Tickers SNGX
Exposures Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Phase 1 Data for Lyme Disease Candidate TNX-4800, Plans Phase 2 Study
Via Investor Brand Network
Tickers TNXP
Exposures Product Safety
News headline image
The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals
Via Finterra
Topics Economy Initial Public Offering Intellectual Property
Tickers ALKS CNTA GS JAZZ LLY TAK
Exposures Intellectual Property Interest Rates Product Safety
News headline image
The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience
Via Finterra
Topics Economy Intellectual Property
Tickers BIIB BLK CNTA LLY NVO RHHBY
Exposures Intellectual Property Interest Rates Product Safety
News headline image
Bionic Intelligence Research Agent Now Commercially Live for Secure, Scalable, Autonomous Solutions in Global Biotech and Pharma Industries: KALA BIO, Inc. (Nasdaq: KALA)
Via Get News
Topics Artificial Intelligence Intellectual Property
Tickers KALA
Exposures Artificial Intelligence Intellectual Property Product Safety
News headline image
Agios Pharma Rallies On A Surprise FDA Move In Sickle Cell Disease ↗
Via Investor's Business Daily
Exposures Product Safety
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Selects Global Brand Name Candidate for AVERSA(TM) Fentanyl Patch
Via Investor Brand Network
Tickers BMWYY NTRB
Exposures Product Safety
BioMedNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Advances AI-Driven Oncology Pipeline With Multiple 2026 Milestones in View
Via Investor Brand Network
Topics Artificial Intelligence
Tickers BMWYY LTRN
Exposures Artificial Intelligence Product Safety
News headline image
2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More ↗
Via The Motley Fool
Tickers HCA LLY VKTX
Exposures Product Safety
News headline image
OS Therapies Completes Submission of Biomarker & Clinical Data for U.S. FDA Pre-BLA Meeting, Reports Full Year 2025 Financial Results and Provides Business Update
Via Newsfile
Tickers OSTX
Exposures Product Safety
News headline image
Why Is PepGen Stock Sinking Tuesday? ↗
Via Benzinga
Exposures Product Safety
News headline image
AI-Powered “Depression Thermometer” to Aid Interventional Psychiatry Network via Strategic Partnership with Emobot for NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Tickers NRXP
Exposures Product Safety
News headline image
NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
News headline image
Biogen Stock Pops After FDA Approves New High-Dose Spinraza For Spinal Muscular Atrophy ↗
Via Benzinga
Exposures Product Safety
News headline image
From Shenzhen to the World: How Sunflower Dental Lab Became a Global Leading Dental Implant Service Powerhouse
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
News headline image
CCHR: Psychiatric Drugs Fuel Rising Death Toll: National Adverse Drug Event Awareness Day Confronts America's Medication Crisis
Via PRLog
Topics Death
Exposures Death Product Safety
News headline image
Sysco’s $29 Billion Bet: Foodservice Giant Swallows Jetro Restaurant Depot to Dominate Cash-and-Carry Market
Via MarketMinute
Topics Economy
Tickers ARM COST PFGC SYY USFD WMT
Exposures Interest Rates Product Safety Supply Chain
News headline image
MoonLake Says Lead Drug Shows Durable Response, Eyes FDA Filing ↗
Via Benzinga
Exposures Product Safety
News headline image
Industrial Intelligence: Stellantis’ High-Stakes AI Pivot with Palantir
Via Finterra
Topics Artificial Intelligence Economy Product Recall
Tickers BYDDY F GM PLTR STLA TSLA
Exposures Artificial Intelligence Interest Rates Legal
News headline image
Altria's Oral Nicotine Pouch Product Is Going Nationwide. Is the Stock a Buy in 2026? ↗
Via The Motley Fool
Tickers MO
Exposures Product Safety
News headline image
Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
Via Newsfile
Tickers PHIO
Exposures Product Safety
News headline image
CCHR: Time to End the Psychotropic Pill Epidemic – National Adverse Drug Event Awareness Day Exposes America’s Hidden Medication Crisis
Via Send2Press
Topics Death
Exposures Death Product Safety
News headline image
Psilocybin-Assisted Therapy: A Modern Approach to Mental Health Innovation
Via BusinesNews Wire
Exposures Product Safety
News headline image
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
SLNO DEADLINE FOR LEADERSHIP is May 5, 2026 in a Securities Fraud Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) - Contact Kaplan Fox
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers SLNO
Exposures Financial Legal Product Safety
News headline image
SLNO DEADLINE FOR LEADERSHIP is May 5, 2026 in a Securities Fraud Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) - Contact Kaplan Fox
Via NewMediaWire
Topics Fraud Lawsuit
Tickers SLNO
Exposures Financial Legal Product Safety
News headline image
Deadline is April 21, 2026 to Lead in Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today